Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05034432 · ClinicalTrials.gov registry record · Phase 4

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

A Phase 4 study of Cardiomyopathies and Arrythmia, sponsored by University of Rochester.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
19
Study locations

NCT05034432: Recruiting Phase 4 study of Cardiomyopathies and Arrythmia, sponsored by University of Rochester.

NCT05034432 is a Phase 4 study of Cardiomyopathies and Arrythmia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 630-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (84% lower). The trial reports 19 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05034432, a Phase 4 study of Cardiomyopathies and Arrythmia, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
19
Study locations

Study Summary

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery

Primary Outcome

Total VTA events, after accounting for the competing risk of death

Interventions

  • PROCEDURE Intra-Op Prophylactic VT ablation
  • OTHER Conventional Management

Study Locations (19)

California

  • UCLA Cardiac Arrthmia Center - Los Angeles
  • University of California San Francisco - San Francisco

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University - Atlanta

New York

  • Columbia University Medical Center - New York
  • University of Rochester - Rochester

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • UPMC - Pittsburgh

Arizona

  • Banner University Medical Center - Phoenix

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Indiana

  • Ascension St. Vincent Indianapolis - Indianapolis

Kentucky

  • Univedrsity of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-05-27
Est. Completion 2027-06-30
Phase Phase 4
University of Rochester

636 total trials

What NCT05034432 shows while recruiting

NCT05034432 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 630-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 2 interventions - of which Intra-Op Prophylactic VT ablation is the first listed.

NCT05034432 lists 19 locations in 15 states (California, Georgia, New York).

Frequently Asked Questions

What is clinical trial NCT05034432 about?

NCT05034432 is a clinical study titled "The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients". To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery

What is the current status of trial NCT05034432?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2022-05-27. Estimated completion is 2027-06-30.

What conditions does trial NCT05034432 study?

This clinical trial studies the following conditions: Cardiomyopathies, Arrythmia.

What interventions are being tested in trial NCT05034432?

The interventions under investigation include: Intra-Op Prophylactic VT ablation (PROCEDURE), Conventional Management (OTHER).

Who is sponsoring clinical trial NCT05034432?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05034432 being conducted?

This trial has 19 study locations across Arizona, California, District of Columbia, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiomyopathies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05034432's enrollment target sits among peer trials

100 13th of 17 higher than 5 of 17 other Cardiomyopathies trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiomyopathies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05034432, the US trial registry maintained by the National Library of Medicine. NCT05034432 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.